Sector ratings Laboratorios Farmaceuticos Rovi, S.A. OTC Markets
Stocks
LABFF
ES0157261019
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.86 USD | -27.31% |
|
-.--% | - |
| 05-13 | Spanish stocks - Factors to watch on May 13 | RE |
| 05-09 | Laboratorios Farmaceuticos Rovi, S.A., Q1 2026 Earnings Call, May 06, 2026 |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 1,007B | A | |||||||
| 567B | BBB | |||||||
| 392B | - | AA | - | - | ||||
| 328B | AA | |||||||
| 277B | AAA | |||||||
| 275B | A | |||||||
| 196B | A | |||||||
| 189B | A | |||||||
| 154B | AA | |||||||
| 148B | A | |||||||
| 115B | A | |||||||
| 114B | AA | |||||||
| 105B | AA | |||||||
| 105B | AA | |||||||
| 76.33B | AA | |||||||
| 50.19B | AA | |||||||
| 46.79B | AA | |||||||
| 41.39B | AA | |||||||
| 39.23B | - | |||||||
| Average | 222.5B | AA | |||||||
| Weighted average by Cap. | AA |
Select your edition
All financial news and data tailored to specific country editions
